Image

On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety

On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study is evaluating On-Trac (Online Training After Cancer), an online educational intervention to teach adult cancer survivors strategies to address anxiety based on Cognitive-Behavioral Therapy (CBT) and Acceptance Commitment Therapy (ACT)

The name of the study intervention is Online Training After Cancer (On-Trac)

Description

This is a minimal-risk behavioral optimization trial to optimize and refine On-Trac (Online Training After Cancer), an online educational intervention designed to help adult cancer survivors.

The research study procedures include screening for eligibility, questionnaires and interviews.

Participation in the study involves:

  • Completing online survey using using a web-based survey platform for baseline assessment
  • Taking part in an online, 120 minute, group session via video conference platform and completing an online questionnaire.
  • Completing 1-2, 30-40 minute, individual coaching sessions 1-7 days after group educational video session.
  • Completing follow-up questionnaire using a web-based survey platform and telephone interview at 4, and 8 weeks after the group education session.
  • Participants will receive gift card incentives for completing the brief post-session evaluation and the longer follow-up questionnaires and interview, with a maximum total of $90.

It is expected about 80 people will participate in this research study and will be grouped in four aged based cohorts of 15-20 participants.

Eligibility

Inclusion Criteria:

  • Age ≥ 18
  • A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior.
  • No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned.
  • Significant anxiety as evidenced by both of the following
    • Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder, Agoraphobia, Specific Phobia, or Illness Anxiety Disorder.
    • A score ≥ 6 on the Overall Anxiety Severity and Impairment Scale (OASIS).
  • Regular access to the internet.
  • Ability to read and write in English.

Exclusion Criteria:

  • Significant symptoms of Panic Disorder in the prior 3 months, including anticipatory anxiety of having a future panic attack or avoidance symptoms associated with panic attacks, as assessed by three SCID-5 items from the panic attack disorder module.
  • Significant symptoms of Obsessive Compulsive Disorder, as evidenced by any obsessions over the past 3 months, as assessed by three SCID items from the Obsessive Compulsive Disorder module.
  • Psychiatric hospitalizations or emergency room visits for psychiatric care in the prior 2 years.
  • Any use in the last month of emergent or "rescue" anxiety medication (e.g., Ativan, Xanax, Valium) or self-prescribed substances (i.e., marijuana) at the onset of anxiety symptoms or when entering a situation where they expect to experience anxiety.
  • Any significant marijuana use which could impact anxiety symptoms, as evidenced by one of the following:
    • 4 days of marijuana use in any week in the last month
    • 20 milligrams of THC (Tetrahydrocannabinol) products in any week in the last month.
  • Participation in any CBT or ACT-based behavioral or education intervention for anxiety in the past 2 years. This includes in-person, asynchronous, and synchronous online anxiety programs, and therapy that includes these skills. This does not include independent use of any self-help materials (i.e., workbooks, books).
  • Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all parts of the study independently.

Study details
    Cancer
    Survivorship
    Anxiety

NCT07305740

Dana-Farber Cancer Institute

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.